Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SF3B1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | WRN | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | IL18RAP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RAVER2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RAD54L2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | OR5J2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | NDUFS8 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SEC14L6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | MYBL1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | COX7A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |